| Financial Year |
March 31 2023 |
| Monetary Funds |
3,890,870,268.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,899,611.72 |
| Accounts Receivable |
722,406,921.13 |
| Advances to Suppliers |
666,450,024.92 |
| Other Receivables |
308,355,507.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,783,848,235.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
593,933,497.75 |
| Total Current Assets |
12,990,493,336.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,357,276.88 |
| Investment Properties |
-- |
| Fixed Assetes |
5,146,462,778.11 |
| Under-construction Projects |
548,691,693.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
379,262,172.95 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
273,301,484.87 |
| R&D expenses |
12,982,627.27 |
| Goodwill |
342,959,059.06 |
| Long-Term Deferred and Prepaid Expenses |
20,874,544.06 |
| Deferred Income Tax Assets |
43,060,894.86 |
| Other Non-Current Assets |
33,686,000.00 |
| Sub-Total of Non-Current Assets |
7,384,277,890.65 |
| Total Assets |
20,374,771,227.30 |
| Short-Term Loans |
3,818,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
521,127,043.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
311,594,261.32 |
| Taxes Payable |
24,478,106.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
989,224,193.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,083,465,140.78 |
| Other Current Liabilities |
77,814,583.52 |
| Sub-Total of Current Liabilities |
7,315,031,840.16 |
| Long-term Loans |
2,878,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
714,384.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,290,328,060.73 |
| Total Liabilities |
10,605,359,900.89 |
| Paid-In Capital(Or Share Stock) |
1,354,581,052.00 |
| Capital Surplus |
3,936,237,761.32 |
| Surplus Reserve |
439,075,429.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,290,848,706.52 |
| Minority Stockholder's Interest |
1,730,023,440.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,039,387,885.55 |
| Owner's Equity（Stockholder's Equity） |
9,769,411,326.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,374,771,227.30 |
